Driving excellence in aseptic fill-finish: Our strategic partnership with Stäubli Robotics
At 3P innovation, we engineer automation with purpose - solutions that don’t just meet the demands of aseptic manufacturing but redefine what’s...
Dr. Dave Seaward : 28 February 2022
As we continue to explore the world of cell and gene therapy, we now take a look at managing costs and scale up risks for medical devices.
Author Dave Seward, discusses how the principles of Quality by Design (QbD) and Design for Manufacture (DfM) can be applicable to ATMPs. Read this blog now!
At 3P innovation, we engineer automation with purpose - solutions that don’t just meet the demands of aseptic manufacturing but redefine what’s...
Pharmaceutical extrusion is a critical enabler in the manufacture of advanced drug delivery systems, from long-acting injectables to solid implants....
Before delving into some technical details of cell and gene therapy manufacturing, it’s worth pausing to reflect on the human stories that drive this...